Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Research and Innovation Action · Running

PanCare4AYA Patient-centred, evidence-based late effect screening and follow-up care of survivors of adolescent and young adult cancer

Coordinator
Prinses Maxima Centrum Voor Kinderoncologie BV, Netherlands
Runs
1 April 2025 to 31 March 2030
Status
Running
EU funding
€5.8m
Total cost
€5.8m
Partners
31 organisations in 13 countries
Type
Research and Innovation Action
Grant agreement
101213107

What the project is doing

In the project's own words, from its summary on CORDIS.

Survivors of AYA cancer are at risk of treatment-related mortality and morbidity (late effects). The impact on the quality of life (QoL) of AYA cancer survivors and their families, as well as the societal and economic burdens, is significant. However, these impacts can be prevented or reduced by long-term, systematic screening and follow-up (Survivorship Care), which enables the early detection of treatable late effects and timely interventions to preserve health, increase empowerment, manage chronic conditions and improve QoL.

PanCare4AYA will improve Survivorship Care for AYA cancer survivors across Europe by developing an international clinical guideline for screening and follow-up. This guideline will be implemented via a novel person-centred screening programme (AYA Cancer Survivor Screen). An implementation study involving 1,000 AYA cancer survivors in 11 European countries (Croatia, Czech Republic, France, Germany, Italy, Lithuania, Netherlands, Norway, Sweden, Switzerland, United Kingdom) will be conducted to test the AYA Cancer Survivor Screen programme, including peer support.

The study will look at effectiveness (empowerment, mental health, psychosocial functioning and other QoL-related outcomes), healthcare delivery and screening-related health, experiences of AYA cancer survivors and HCPs with implementing the state-of-the-art screening programme within a range of different healthcare settings, and feasibility. Innovative digital tools will be used in France, Italy, Lithuania and Netherlands.

Ensuring the scalability of the AYA Cancer Survivor Screen programme is crucial for achieving enduring, real-world improvements to Survivorship Care for AYA cancer survivors. Therefore, the project includes the assessment of barriers and facilitators for the screening programme and development of freely available materials to support sustainable maintenance and scale-up of AYA Cancer Survivor Screen in additional clinics in future.

This action is part of the Cancer Mission cluster of projects on “Quality of life (AYA)”.

Topics

Who is involved

OrganisationCityCountryRole
Prinses Maxima Centrum Voor Kinderoncologie BVUtrechtNetherlandsCoordinator
European Cancer OrganisationBruxelles / BrusselBelgiumParticipant
Siop EuropeBruxelles / BrusselBelgiumParticipant
Stiftung Ostschweizer KinderspitalSankt GallenSwitzerlandAssociatedpartner
Fakultni Nemocnice BrnoBrnoCzechiaParticipant
Universitaet LeipzigLeipzigGermanyParticipant
Universitaet Zu LuebeckLubeckGermanyThird party
Universitaetsmedizin Der Johannes Gutenberg-Universitaet MainzMainzGermanyParticipant
Universitatsklinikum Schleswig-HolsteinLübeckGermanyParticipant
Centre Hospitalier Regional Et Universitaire De BrestBrestFranceThird party
Centre Hospitalier Universitaire D'angersAngersFranceThird party
Centre Hospitalier Universitaire De NantesNantesFranceThird party
Chu Cote De Nacre - CaenCaen Cedex 5FranceThird party
Gcs Hopitaux Universitaires Grand OuestAngersFranceParticipant
Klinika Za Djecje Bolesti ZagrebZagrebCroatiaParticipant
Pintail LtdBlackrockIrelandParticipant
Datariver SRLModenaItalyParticipant
Fondazione Policlinico Universitario Agostino Gemelli IrccsRomaItalyParticipant
Istituto Giannina GasliniGenovaItalyParticipant
Nacionalinis Vezio InstitutasVilniusLithuaniaThird party
Vilniaus Universiteto Ligonine Santaros KlinikosVilniusLithuaniaParticipant
Academisch Ziekenhuis GroningenGroningenNetherlandsParticipant
Childhood Cancer InternationalAmsterdamNetherlandsParticipant
PancareBussumNetherlandsParticipant
Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek ZiekenhuisAmsterdamNetherlandsParticipant
Stichting Nederlands Instituut Voor Onderzoek Van De GezondheidszorgUtrechtNetherlandsParticipant
Stichting Radboud Universitair Medisch CentrumNijmegenNetherlandsParticipant
Oslo Universitetssykehus HfOsloNorwayParticipant
Universitetet I OsloOsloNorwayParticipant
Region StockholmStockholmSwedenParticipant
University of LeedsLeedsUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI